Effects of Stress and Other Factors on Opiate Drug Choice.
NCT00684840 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16
Last updated 2012-06-05
Summary
The purpose is to study the extent to which stress and other factors, including money, the amount of drug available and the amount of work effort, affect drug choice.
This study will assess whether exposure to yohimbine, a drug stressor, increases opioid craving- and -seeking behavior. We will determine whether these behavioral outcomes are associated with biobehavioral stress markers: increased saliva cortisol levels, cardiovascular response (heart rate and blood pressure), and negative mood state.
Conditions
- Heroin Dependence
- Opioid-Related Disorders
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH -
Wayne State University
lead OTHER
Principal Investigators
-
Mark Greenwald, PhD · Wayne State University
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-03-31
- Primary Completion
- 2011-12-31
- Completion
- 2011-12-31
Countries
- United States
Study Locations
More Related Trials
-
Impact of Sustained Release d-Amphetamine on Choice Between Cocaine and a Non-Drug Reinforcer
NCT02383043 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Characterizing Methamphetamine Withdrawal in Recently Abstinent Methamphetamine Users: A Pilot Study
NCT00653263 ·Status: COMPLETED
-
Acute and Short-term Effects of Cannabidiol Admin on Cue-induced Craving in Drug-abstinent Heroin Dependent Humans
NCT01605539 ·Status: COMPLETED ·Phase: PHASE2
-
Individualized Neuromodulation of Craving Control for Meth Use Disorders
NCT06695637 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
An Eval of Neurocognitive Function, Oxidative Damage, and Their Association With Outcomes in METH and Cocaine Abusers.
NCT00628927 ·Status: COMPLETED
-
Studying Amphetamine Withdrawal in Humans
NCT01215929 ·Status: COMPLETED ·Phase: PHASE2
-
Stress Hormones and Human Cocaine Use - 7
NCT00000290 ·Status: COMPLETED ·Phase: PHASE1
-
Developing a Clinical Outcome Assessment for Opioid Craving
NCT05109429 ·Status: RECRUITING ·Phase: NA
-
Tyrosine for Methamphetamine Dependence - 1
NCT00000322 ·Status: COMPLETED ·Phase: PHASE2
-
Modafinil vs Placebo for the Treatment of Methamphetamine Dependence
NCT00469508 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacotherapy & CM for Opioid and Cocaine Dependence
NCT00838981 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Brain Changes in Stimulant Dependent Subjects - 8
NCT00000343 ·Status: COMPLETED ·Phase: PHASE4
-
Methylphenidate to Treat Methamphetamine Dependence
NCT01044238 ·Status: UNKNOWN ·Phase: PHASE2
-
Development of Human Laboratory Study Model of Cocaine Relapse Prevention II - 1
NCT00094315 ·Status: UNKNOWN ·Phase: PHASE1
-
Phase 2, Multi-Center Trial of Modafinil for Methamphetamine Dependence
NCT00520286 ·Status: COMPLETED ·Phase: PHASE2
-
Substance Abuse Pre-Treatment Screening Study
NCT00439049 ·Status: RECRUITING
-
Brain Networks and Addiction Susceptibility
NCT01924468 ·Status: COMPLETED ·Phase: PHASE1
-
Cocaine-Methylphendidate Interaction Study - 4
NCT00015067 ·Status: COMPLETED ·Phase: PHASE1
-
Behavioral Effects of Drugs: Inpatient (35)
NCT03519022 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1
NCT00040040 ·Status: UNKNOWN ·Phase: PHASE1
-
Effectiveness of Bupropion Combined With Behavioral Therapy for Treating Methamphetamine Dependence - 2
NCT00135785 ·Status: COMPLETED ·Phase: PHASE2
-
Disulfiram for Cocaine Abuse in Buprenorphine Treatment
NCT00913484 ·Status: COMPLETED ·Phase: PHASE2
-
Stress, Distress Intolerance, and Drug Dependence
NCT00430482 ·Status: COMPLETED ·Phase: NA
-
Pain Catastrophizing and Prescription Opioid Craving
NCT04097743 ·Status: TERMINATED ·Phase: NA
-
Neuromodulation and Cognitive Training for Substance Use Disorders
NCT04426214 ·Status: RECRUITING ·Phase: NA